We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHBI icon
2901
Shore Bancshares
SHBI
$817M
$351K ﹤0.01%
+17,201
New +$353K
SLNH icon
2902
Soluna Holdings
SLNH
$192M
$346K ﹤0.01%
1,258
-435
-26% -$108K
WNS
2903
DELISTED
WNS Holdings
WNS
$346K ﹤0.01%
+4,044
New +$345K
PXE icon
2904
Invesco Energy Exploration & Production ETF
PXE
$84.6M
$345K ﹤0.01%
+12,422
New +$298K
AIFU
2905
AIFU Inc
AIFU
$190M
$343K ﹤0.01%
118
-110
-48% -$305K
KRUS icon
2906
Kura Sushi USA
KRUS
$583M
$342K ﹤0.01%
6,204
-3,298
-35% -$170K
REPL icon
2907
Replimune Group
REPL
$449M
$342K ﹤0.01%
+20,143
New +$380K
CLIM.WS
2908
CALL
DELISTED
Climate Real Impact Solutions II Acquisition Corporation Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
CLIM.WS
$342K ﹤0.01%
34,995
ATER icon
2909
Aterian
ATER
$4.21M
$341K ﹤0.01%
+11,654
New +$427K
OPAD.WS
2910
CALL
DELISTED
Offerpad Solutions Inc. Warrants, Every 15 warrants will be exercisable for one share of Class A Common Stock at an exercise price of $172.50 per share of Class A Common Stock
OPAD.WS
$341K ﹤0.01%
68,308
+3,075
+5% +$1.93K
MHK icon
2911
Mohawk Industries
MHK
$7.14B
$339K ﹤0.01%
2,734
-22,279
-89% -$3.34M
VVX icon
2912
V2X
VVX
$2.82B
$339K ﹤0.01%
9,438
+8,408
+816% +$359K
EDIT icon
2913
Editas Medicine
EDIT
$402M
$337K ﹤0.01%
17,725
-368,902
-95% -$6.86M
CLPT icon
2914
ClearPoint Neuro
CLPT
$436M
$333K ﹤0.01%
32,033
-26,532
-45% -$241K
DTSS icon
2915
Datasea Intelligent Technology Ltd
DTSS
$8.76M
$331K ﹤0.01%
+7,978
New +$228K
PHAT icon
2916
Phathom Pharmaceuticals
PHAT
$930M
$330K ﹤0.01%
24,352
-7,813
-24% -$126K
TAP icon
2917
Molson Coors Class B
TAP
$7.97B
$327K ﹤0.01%
6,116
-93,148
-94% -$4.69M
YSG
2918
Yatsen Holding
YSG
$322M
$327K ﹤0.01%
94,836
+46,877
+98% +$314K
IVC
2919
DELISTED
Invacare Corporation
IVC
$327K ﹤0.01%
231,913
+103,912
+81% +$222K
RRR icon
2920
Red Rock Resorts
RRR
$3.87B
$326K ﹤0.01%
+6,709
New +$320K
VRDN icon
2921
Viridian Therapeutics
VRDN
$2.15B
$326K ﹤0.01%
17,563
-70,842
-80% -$1.36M
CALY
2922
Callaway Golf Company
CALY
$3.28B
$324K ﹤0.01%
13,828
-77,220
-85% -$1.87M
CSII
2923
DELISTED
Cardiovascular Systems, Inc.
CSII
$323K ﹤0.01%
14,277
-60,173
-81% -$1.17M
FXY icon
2924
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
$322K ﹤0.01%
4,179
-967
-19% -$77.9K
HYZNW
2925
CALL
DELISTED
Hyzon Motors Inc. Warrants
HYZNW
$319K ﹤0.01%
50,000

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.